The global removal of GM-CSF leads to increased adiposity, profound reduction in adipose tissue GM-CSF driven myeloid cells, that is accompanied with an increase in DHTKD1 levels, lower plasma 2-AA levels, and protection from diet-induced insulin resistance. The gene discussed is CSF2; the disease is Insulin resistance.